GSK’s $10.6B Nuvalent takeover fails to impress investors as shares fall: here's why Invezz 6d Lung Cancer Mergers and Acquisitions Pharma
GSK falls after agreeing £8bn Nuvalent takeover to bolster oncology pipeline Proactive Investors (UK) 6d FTSE 100 Lung Cancer Mergers and Acquisitions
GSK agrees £8bn Nuvalent takeover to bolster oncology pipeline Proactive Investors (UK) 6d Mergers and Acquisitions Stock Markets (World) FTSE 100
GSK's momelotinib receives orphan drug designation from US and EU watchdogs ShareCast 3d FTSE 100 Pharma Business Article paywall
GSK's momelotinib receives orphan drug designation from US and EU watchdogs ShareCast 3d Article paywall
Roche and Nestlé fear talent crunch as Switzerland puts population cap to the polls Fortune 3d Switzerland Roche Swiss Economy
3 Reasons to buy Eli Lilly stock like there's no tomorrow The Motley Fool 1d Eli Lilly Novo Nordisk Mounjaro
